Avidity Biosciences
RNA
#2594
Rank
A$8.45 B
Marketcap
$70.83
Share price
-1.66%
Change (1 day)
722.22%
Change (1 year)

Avidity Biosciences (RNA) - Cash on Hand

Cash on Hand as of June 2024 : A$1.96 Billion

According to Avidity Biosciences's latest financial reports the company has A$1.96 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Avidity Biosciences - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.87 B-2.63%
2022-12-31A$0.89 B60.44%
2021-12-31A$0.55 B31.08%
2020-12-31A$0.42 B215.91%
2019-12-31A$0.13 B2979.72%
2018-12-31A$4.38 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$1.53 B-21.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$14.19 M-99.28%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.81 B-7.75%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.67 B-65.95%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.46 B-76.53%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
A$15.08 B 666.10%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.51 B 230.91%๐Ÿ‡ฌ๐Ÿ‡ง UK